[시장보고서]심혈관 초음파 시장 규모, 점유율, 동향 분석 리포트 : 유형별, 기술별, 디스플레이별, 최종 용도별, 지역별 및 부문 예측(2024-2030년)

심혈관 초음파 시장 규모, 점유율, 동향 분석 리포트 : 유형별, 기술별, 디스플레이별, 최종 용도별, 지역별 및 부문 예측(2024-2030년)

Cardiovascular Ultrasound Market Size, Share & Trends Analysis Report By Type, By Technology, By Display, By End-use, By Region, And Segment Forecasts, 2024 - 2030

상품코드 : 1553563

리서치사 : Grand View Research

발행일 : 2024년 08월

페이지 정보 : 영문 220 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,590,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,034,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 12,922,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

심혈관 초음파 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 심혈관 초음파 시장 규모는 2030년까지 35억 2,000만 달러에 달하며, 2024-2030년 CAGR 5.41%로 확대할 것으로 예측됩니다.

심혈관 초음파 검사를 촉진하는 주요 요인은 새로운 이미징 기술로 인해 심초음파 장비에서 얻은 이미지의 정확도와 해상도가 향상된 것입니다. 이를 통해 임상의는 질병을 더 쉽게 식별하고 진단할 수 있게 되었습니다. 또한 비침습적 진단 옵션을 제공하므로 침습적 시술보다 선호되는 경우가 많습니다.

심혈관 초음파 검사는 기존 방식에 비해 빠른 회복, 입원 기간 단축, 수술 후 합병증 감소 등의 이점이 있습니다. 노인 인구 증가와 함께 이러한 장점은 예측 기간 중 심혈관 초음파 진단에 대한 수요를 촉진할 것으로 예상됩니다.

북미는 2022년에 가장 큰 시장 점유율을 차지했습니다. 유리한 상환 프레임워크와 다수의 업계 기업의 존재가 이 지역 성장의 주요 요인 중 일부입니다. 노인 인구 증가와 정교한 의료 인프라가 결합되어 이 지역 시장 성장을 더욱 촉진할 것으로 예상됩니다. 또한 건강에 대한 인식이 높아지면서 수요를 견인하고 있습니다.

COVID-19는 CVUS에 큰 영향을 미치고 있습니다. 팬데믹의 가장 두드러진 영향 중 하나는 CVUS와 관련된 선택적 시술의 지연입니다. 그 결과 영상진단 장비와 서비스에 대한 수요가 감소하고 있습니다. 그러나 전염병은 또한 원격 모니터링 장비 및 가상 진료와 같은 원격의료 도입 증가로 이어졌습니다. 이로 인해 휴대용 장비의 사용이 증가하고 시장이 확대되고 있습니다.

심혈관 초음파 시장 보고서 하이라이트

경흉부심장초음파(TTE) 분야가 2023년 55.4%의 점유율을 차지하며 시장을 장악.
도플러 부문은 2023년 42.6%의 점유율로 시장을 장악하고 예측 기간 중 가장 빠른 CAGR로 성장할 것으로 예상됩니다. 이는 주로 상세한 혈류 및 혈류 속도 측정을 제공하는 고급 기능 덕분입니다.
컬러 부문은 2023년 84.0%의 점유율로 시장을 장악하고 예측 기간 중 가장 빠른 속도로 성장할 것으로 예상됩니다. 이는 주로 심장 및 혈관계내 혈류 동역학을 시각화하고 평가할 수 있는 뛰어난 능력에 기인합니다.
병원 부문은 2023년 45.9% 이상의 점유율로 시장을 장악했습니다. 이러한 우위는 외래 진료(OPD) 방문 및 입원 증가와 같은 몇 가지 요인에 기인합니다.
북미 심혈관 초음파 시장은 2023년 29.0%의 가장 큰 점유율을 차지했습니다. 이는 심혈관 초음파를 포함한 첨단 의료 기술의 보급을 촉진하는 견고한 의료 인프라의 존재에 기인합니다.
아시아태평양 심혈관 초음파 시장은 예측 기간 중 5.82%의 가장 빠른 CAGR을 나타낼 것으로 예상됩니다. 이는 주로 이 지역 전체에서 의료 인프라의 급속한 확장과 첨단 의료 기술에 대한 투자가 증가하고 있기 때문입니다.

주요 시장 참여 기업에 의한 최근 동향과 영향 분석
기업/경쟁의 분류
주요 기업의 시장 점유율 분석, 2023년
기업의 포지션 분석
기업 분류(신규 기업, 이노베이터, 리더)
기업 개요
- Koninklijke Philips NV
- GE Healthcare
- Siemens Healthineers AG
- Canon Medical Systems
- Mindray Medical International Limited
- Samsung Medison Co., Ltd.
- FUJIFILM SonoSite, Inc.,
- Konica Minolta Inc.
- Esaote
- Trivitron Healthcare

KSA

영문 목차

영문목차

Cardiovascular Ultrasound Market Growth & Trends:

The global cardiovascular ultrasound market size is expected to reach USD 3.52 billion by 2030 and expand at a CAGR of 5.41% from 2024 to 2030, according to a new report by Grand View Research, Inc. The primary factor driving cardiovascular ultrasounds is that new imaging technologies have improved the accuracy and resolution of images obtained from echocardiography machines. This makes it easier for clinicians to identify and diagnose diseases. Additionally, it provides non-invasive diagnostic options, which are often preferred over invasive procedures.

Benefits associated with cardiovascular ultrasound over conventional methods include quick recovery, reduced span of hospitalization, and fewer post-operative complications. These benefits along with the rising geriatric population are expected to propel the demand for cardiovascular ultrasound diagnosis over the forecast period.

North America captured the largest market share in 2022. A favorable reimbursement framework and the presence of a large number of industry players are some of the major factors which can be attributed to regional growth. The rising geriatric population coupled with sophisticated healthcare infrastructure is expected to further fuel market growth in the region. Furthermore, increasing health awareness is driving demand.

COVID-19 has had a significant impact on CVUS. One of the most noticeable effects of the pandemic has been the delays in elective procedures, including those related to CVUS. As a result, which reduces the demand for imaging equipment and services. However, the pandemic has also led to an increase in telemedicine adoption, which includes the use of remote monitoring devices and virtual consultations. This led to increased use of portable devices and an expansion of the market.

Cardiovascular Ultrasound Market Report Highlights:

The transthoracic echocardiography (TTE) segment dominated the market by capturing a share of 55.4% in 2023.
The doppler segment dominated the market by capturing a 42.6% share in 2023 and is further expected to grow at the fastest CAGR over the forecast period. This is primarily attributed to its advanced capabilities in providing detailed blood flow and velocity measurements.
The color segment dominated the market by capturing a share of 84.0% in 2023 and is expected to grow at the fastest rate over the forecast period. This is primarily attributed to its superior ability to visualize and assess blood flow dynamics within the heart and vascular system.
The hospital segment dominated the market with a share of over 45.9% in 2023. This dominance is attributed to several factors, including the increasing number of outpatient department (OPD) visits and hospital admissions.
North America cardiovascular ultrasound market held the largest share of 29.0% in 2023. This can be attributed to the presence of a robust healthcare infrastructure that facilitates the widespread adoption of advanced medical technologies, including cardiovascular ultrasound.
The cardiovascular ultrasound market in Asia Pacific is estimated to witness the fastest CAGR of 5.82% during the forecast period, primarily due to the rapid expansion of healthcare infrastructure and increasing investments in advanced medical technologies across the region.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. Technology
- 1.2.3. Display
- 1.2.4. End Use
- 1.2.5. Regional scope
- 1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
  - 1.4.5.1. Data for primary interviews in North America
  - 1.4.5.2. Data for primary interviews in Europe
  - 1.4.5.3. Data for primary interviews in Asia Pacific
  - 1.4.5.4. Data for primary interviews in Latin America
  - 1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Technology outlook
- 2.2.3. Display outlook
- 2.2.4. End use outlook
- 2.2.5. Regional outlook
2.3. Competitive Insights

Chapter 3. Cardiovascular Ultrasound Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Increasing prevalence of cardiovascular diseases
  - 3.2.1.2. High adoption of preventive healthcare
  - 3.2.1.3. Technological advancements
- 3.2.2. Market restraint analysis
  - 3.2.2.1. Slower treatment
  - 3.2.2.2. Reimbursement policies
3.3. Cardiovascular Ultrasound Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Economic landscape

Chapter 4. Cardiovascular Ultrasound Market: Type Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Global Cardiovascular Ultrasound Type Market Movement Analysis
4.3. Global Cardiovascular Ultrasound Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Transthoracic echocardiography
- 4.4.1. Transthoracic echocardiography market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Transesophageal echocardiography
- 4.5.1. Transesophageal echocardiography market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Fetal echocardiography
- 4.6.1. Fetal echocardiography market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Others
- 4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Cardiovascular Ultrasound Market: Technology Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Global Cardiovascular Ultrasound Technology Market Movement Analysis
5.3. Global Cardiovascular Ultrasound Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
5.4. 2D
- 5.4.1. 2D market estimates and forecasts 2018 to 2030 (USD Million)
5.5. 3D/4D
- 5.5.1. 3D/4D market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Doppler
- 5.6.1. Doppler market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Cardiovascular Ultrasound Market: Display Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Global Cardiovascular Ultrasound Display Market Movement Analysis
6.3. Global Cardiovascular Ultrasound Market Size & Trend Analysis, by Display, 2018 to 2030 (USD Million)
6.4. B/W
- 6.4.1. B/W market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Color
- 6.5.1. Color market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Cardiovascular Ultrasound Market: End Use Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Global Cardiovascular Ultrasound End Use Market Movement Analysis
7.3. Global Cardiovascular Ultrasound Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
7.4. Hospitals
- 7.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Diagnostic Centers
- 7.5.1. Diagnostic centers market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Ambulatory Care Centers
- 7.6.1. Ambulatory care centers market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Others
- 7.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Cardiovascular Ultrasound Market: Regional Estimates & Trend Analysis By Type, Technology, Display, End Use

8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.5. North America
- 8.5.1. U.S.
  - 8.5.1.1. Key country dynamics
  - 8.5.1.2. Competitive scenario
  - 8.5.1.3. Regulatory framework
  - 8.5.1.4. Reimbursement structure
  - 8.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.2. Canada
  - 8.5.2.1. Key country dynamics
  - 8.5.2.2. Competitive scenario
  - 8.5.2.3. Regulatory framework
  - 8.5.2.4. Reimbursement structure
  - 8.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.3. Mexico
  - 8.5.3.1. Key country dynamics
  - 8.5.3.2. Competitive scenario
  - 8.5.3.3. Regulatory framework
  - 8.5.3.4. Reimbursement structure
  - 8.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Europe
- 8.6.1. UK
  - 8.6.1.1. Key country dynamics
  - 8.6.1.2. Competitive scenario
  - 8.6.1.3. Regulatory framework
  - 8.6.1.4. Reimbursement structure
  - 8.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.2. Germany
  - 8.6.2.1. Key country dynamics
  - 8.6.2.2. Competitive scenario
  - 8.6.2.3. Regulatory framework
  - 8.6.2.4. Reimbursement structure
  - 8.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.3. France
  - 8.6.3.1. Key country dynamics
  - 8.6.3.2. Competitive scenario
  - 8.6.3.3. Regulatory framework
  - 8.6.3.4. Reimbursement structure
  - 8.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.4. Italy
  - 8.6.4.1. Key country dynamics
  - 8.6.4.2. Competitive scenario
  - 8.6.4.3. Regulatory framework
  - 8.6.4.4. Reimbursement structure
  - 8.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.5. Spain
  - 8.6.5.1. Key country dynamics
  - 8.6.5.2. Competitive scenario
  - 8.6.5.3. Regulatory framework
  - 8.6.5.4. Reimbursement structure
  - 8.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.6. Norway
  - 8.6.6.1. Key country dynamics
  - 8.6.6.2. Competitive scenario
  - 8.6.6.3. Regulatory framework
  - 8.6.6.4. Reimbursement structure
  - 8.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.7. Sweden
  - 8.6.7.1. Key country dynamics
  - 8.6.7.2. Competitive scenario
  - 8.6.7.3. Regulatory framework
  - 8.6.7.4. Reimbursement structure
  - 8.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.8. Denmark
  - 8.6.8.1. Key country dynamics
  - 8.6.8.2. Competitive scenario
  - 8.6.8.3. Regulatory framework
  - 8.6.8.4. Reimbursement structure
  - 8.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Asia Pacific
- 8.7.1. Japan
  - 8.7.1.1. Key country dynamics
  - 8.7.1.2. Competitive scenario
  - 8.7.1.3. Regulatory framework
  - 8.7.1.4. Reimbursement structure
  - 8.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.2. China
  - 8.7.2.1. Key country dynamics
  - 8.7.2.2. Competitive scenario
  - 8.7.2.3. Regulatory framework
  - 8.7.2.4. Reimbursement structure
  - 8.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.3. India
  - 8.7.3.1. Key country dynamics
  - 8.7.3.2. Competitive scenario
  - 8.7.3.3. Regulatory framework
  - 8.7.3.4. Reimbursement structure
  - 8.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.4. Australia
  - 8.7.4.1. Key country dynamics
  - 8.7.4.2. Competitive scenario
  - 8.7.4.3. Regulatory framework
  - 8.7.4.4. Reimbursement structure
  - 8.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.5. South Korea
  - 8.7.5.1. Key country dynamics
  - 8.7.5.2. Competitive scenario
  - 8.7.5.3. Regulatory framework
  - 8.7.5.4. Reimbursement structure
  - 8.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.6. Thailand
  - 8.7.6.1. Key country dynamics
  - 8.7.6.2. Competitive scenario
  - 8.7.6.3. Regulatory framework
  - 8.7.6.4. Reimbursement structure
  - 8.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.8. Latin America
- 8.8.1. Brazil
  - 8.8.1.1. Key country dynamics
  - 8.8.1.2. Competitive scenario
  - 8.8.1.3. Regulatory framework
  - 8.8.1.4. Reimbursement structure
  - 8.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8.2. Argentina
  - 8.8.2.1. Key country dynamics
  - 8.8.2.2. Competitive scenario
  - 8.8.2.3. Regulatory framework
  - 8.8.2.4. Reimbursement structure
  - 8.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.9. MEA
- 8.9.1. South Africa
  - 8.9.1.1. Key country dynamics
  - 8.9.1.2. Competitive scenario
  - 8.9.1.3. Regulatory framework
  - 8.9.1.4. Reimbursement structure
  - 8.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 8.9.2. Saudi Arabia
  - 8.9.2.1. Key country dynamics
  - 8.9.2.2. Competitive scenario
  - 8.9.2.3. Regulatory framework
  - 8.9.2.4. Reimbursement structure
  - 8.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 8.9.3. UAE
  - 8.9.3.1. Key country dynamics
  - 8.9.3.2. Competitive scenario
  - 8.9.3.3. Regulatory framework
  - 8.9.3.4. Reimbursement structure
  - 8.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 8.9.4. Kuwait
  - 8.9.4.1. Key country dynamics
  - 8.9.4.2. Competitive scenario
  - 8.9.4.3. Regulatory framework
  - 8.9.4.4. Reimbursement structure
  - 8.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Key company market share analysis, 2023
9.4. Company Position Analysis
9.5. Company Categorization (Emerging Players, Innovators and Leaders
9.6. Company Profiles
- 9.6.1. Koninklijke Philips N.V.
  - 9.6.1.1. Company overview
  - 9.6.1.2. Financial performance
  - 9.6.1.3. Product benchmarking
  - 9.6.1.4. Strategic initiatives
- 9.6.2. GE Healthcare
  - 9.6.2.1. Company overview
  - 9.6.2.2. Financial performance
  - 9.6.2.3. Product benchmarking
  - 9.6.2.4. Strategic initiatives
- 9.6.3. Siemens Healthineers AG
  - 9.6.3.1. Company overview
  - 9.6.3.2. Financial performance
  - 9.6.3.3. Product benchmarking
  - 9.6.3.4. Strategic initiatives
- 9.6.4. Canon Medical Systems
  - 9.6.4.1. Company overview
  - 9.6.4.2. Financial performance
  - 9.6.4.3. Product benchmarking
  - 9.6.4.4. Strategic initiatives
- 9.6.5. Mindray Medical International Limited
  - 9.6.5.1. Company overview
  - 9.6.5.2. Financial performance
  - 9.6.5.3. Product benchmarking
  - 9.6.5.4. Strategic initiatives
- 9.6.6. Samsung Medison Co., Ltd.
  - 9.6.6.1. Company overview
  - 9.6.6.2. Financial performance
  - 9.6.6.3. Product benchmarking
  - 9.6.6.4. Strategic initiatives
- 9.6.7. FUJIFILM SonoSite, Inc.,
  - 9.6.7.1. Company overview
  - 9.6.7.2. Financial performance
  - 9.6.7.3. Product benchmarking
  - 9.6.7.4. Strategic initiatives
- 9.6.8. Konica Minolta Inc.
  - 9.6.8.1. Company overview
  - 9.6.8.2. Financial performance
  - 9.6.8.3. Product benchmarking
  - 9.6.8.4. Strategic initiatives
- 9.6.9. Esaote
  - 9.6.9.1. Company overview
  - 9.6.9.2. Financial performance
  - 9.6.9.3. Product benchmarking
  - 9.6.9.4. Strategic initiatives
- 9.6.10. Trivitron Healthcare
  - 9.6.10.1. Company overview
  - 9.6.10.2. Financial performance
  - 9.6.10.3. Product benchmarking
  - 9.6.10.4. Strategic initiatives

한글목차

심혈관 초음파 시장의 성장과 동향 :

심혈관 초음파 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 개요

제3장 심혈관 초음파 시장의 변수, 동향, 범위

제4장 심혈관 초음파 시장 : 유형별 추정·동향 분석

제5장 심혈관 초음파 시장 : 기술별 추정·동향 분석

제6장 심혈관 초음파 시장 : 디스플레이별 추정·동향 분석

제7장 심혈관 초음파 시장 : 최종 용도별 추정·동향 분석

제8장 심혈관 초음파 시장 : 유형, 기술, 디스플레이, 최종 용도별 지역 추정·동향 분석

제9장 경쟁 구도